article Open AccessTop 1% cited
Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial
Journal of Vascular Surgery · 2004 · Vol. 39(5) · pp. 967–975
A Durazzo✉(Universidade de São Paulo)Fábio Santana Machado(Universidade de São Paulo)Dimas Ikeoka(Universidade de São Paulo)C Bernoche(Universidade de São Paulo)Maristela Monachini(Universidade de São Paulo)Pedro Puech‐Leão(Universidade de São Paulo)Bruno Caramelli(Universidade de São Paulo)
Cardiac, Anesthesia and Surgical OutcomesLipoproteins and Cardiovascular HealthAortic aneurysm repair treatmentsMedicineAtorvastatinPlaceboPerioperativeMyocardial infarctionRandomized controlled trialUnstable anginaRandomizationSurgeryVascular surgery
MeSH terms
AtorvastatinAgedCardiovascular DiseasesDouble-Blind MethodFemaleFollow-Up StudiesHeptanoic AcidsHumansCholesterol, LDLMalePatient CompliancePostoperative ComplicationsProspective StudiesPyrrolesRisk Factors
Funding
- Fundação de Amparo à Pesquisa do Estado de São Paulo
Citations
597
FWCI
29.29
field-weighted impact
References
34
Percentile
100%
vs. same field & year
Citations per year
Cited by
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
Atherosclerosis · 2016 · 1,581 citations
2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management
European Heart Journal · 2014 · 1,651 citations
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
European Heart Journal · 2016 · 3,169 citations
Updated Society for Vascular Surgery guidelines for management of extracranial carotid disease
Journal of Vascular Surgery · 2011 · 607 citations
ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)
European Heart Journal · 2011 · 3,538 citations
ESC/EAS Guidelines for the management of dyslipidaemias
Atherosclerosis · 2011 · 704 citations
2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk
Atherosclerosis · 2019 · 4,829 citations
2019 ESC/EAS Guidelines for the management of dyslipidaemias: <i>lipid modification to reduce cardiovascular risk</i>
European Heart Journal · 2019 · 8,581 citations
References
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial
The Lancet · 2002 · 6,993 citations
ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery—executive summary
Journal of the American College of Cardiology · 2002 · 1,688 citations
Myocardial infarction redefined—a consensus document of The Joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarction
Journal of the American College of Cardiology · 2000 · 4,832 citations
Perioperative Cardiac Morbidity
Anesthesiology · 1990 · 1,189 citations
Coronary Artery Disease in Peripheral Vascular Patients
Annals of Surgery · 1984 · 1,365 citations
Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol Levels
JAMA · 1998 · 5,284 citations
Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
New England Journal of Medicine · 1995 · 7,469 citations
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)
The Lancet · 1994 · 8,489 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.